Technology News and Research

RSS

A better understanding of link between glycemic variability and psychological disorders needed

When blood sugar levels in diabetes are poorly controlled, patients tend to have more complications such as depression and other mood disturbances, including anxiety and anger, and a lower overall quality of life.

3 May 2012

New pressure-technology device effective in reducing incidence of PONV

In a peer-reviewed published study, a new medically engineered pressure-technology disposable adhesive device (Pressure Right-) developed by Pressure Point Inc. has clinically proven to enhance the efficacy of a popular prophylactic antiemetic drug combination in reducing the incidence of postoperative nausea and vomiting (PONV) among high-risk patients after major laparoscopic surgery procedures.

3 May 2012

NJIT professor receives $340,000 NIH grant to investigate membrane proteins

NJIT Associate Professor Edgardo Farinas has been awarded today a three-year $340,000 National Institutes of Health (NIH) grant to investigate spores as a protein display platform for the directed evolution of membrane proteins.

3 May 2012

Viewpoints: The health law's double count on Medicare funding; Pa. budget endangering health safety net; A doctor's call for more texting

One of the enduring mysteries of President Obama's health law is how its spending constraints and payroll tax hikes on high earners can be used to shore up Medicare finances and at the same time pay for a massive new entitlement program. Isn't this double counting?

3 May 2012

Probiodrug AG, collaborators explain interplay of key suspects in Alzheimer’s

Probiodrug AG (Probiodrug), a biotech company developing products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer's disease (AD), today announced its scientists and academics collaborators published seminal findings on the role of pyroglu Aβ in AD pathology in the May 2, 2012 online edition of the journal Nature (DOI: 10.1038/nature11060). The new findings add to the growing body of evidence that pyroglu Aβ plays a crucial role in the initiation of AD. In addition, the research results further elucidate the mechanism by which pyroglu Aβ triggers neuronal toxicity.

3 May 2012

CSI third quarter revenues increase 5% to $21.2 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2012.

3 May 2012

STAAR Surgical first quarter total revenue increases 4% to $15.5M

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported that sales of its Visian ICL product in the first quarter ended March 30, 2012 increased 25% to $8.6 million.

3 May 2012

Bladder tests performed on women before SUI surgery may not be necessary

Invasive and costly tests commonly performed on women before surgery for stress urinary incontinence (SUI) may not be necessary, according to researchers at the University of California San Diego, School of Medicine and the Urinary Incontinence Treatment Network. The study, supported by the National Institutes of Health (NIH), will be released online May 2 by the New England Journal of Medicine.

3 May 2012

Enrollment complete in Hanger’s WalkAide System clinical trial for stroke

Hanger Orthopedic Group, Inc. today announced the completion of enrollment in its pivotal INSTRIDE investigational device exemption (IDE) clinical trial studying the effectiveness of its WalkAide System in the rehabilitation of stroke survivors.

3 May 2012

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

Xcellerex, Inc., a provider of turnkey biomanufacturing solutions, has launched its XDUO Quad single-use mixing system supporting single-use biomanufacturing in upstream and downstream mixing applications and unit operations.

3 May 2012

FDA clears Angioslide’s new 3X100mm PROTEUS device

Angioslide Ltd. a provider of Embolic Capture Angioplasty solutions, today announced that it has received FDA 510(K) clearance for its new 3X100mm PROTEUS device for treating Peripheral Artery Disease in below the knee (BTK) vasculature.

3 May 2012

First anniversary of Capital BlueCross' Accountable Care Arrangement programs

Today marks the one-year anniversary of Capital BlueCross' launch of two Accountable Care Arrangements (ACA). Preliminary results demonstrate that this innovative care delivery model is improving care coordination, lowering the medical cost trend, and improving the member's management of chronic conditions and overall satisfaction with care.

2 May 2012

Levetiracetam to be tested for seizure management in malaria endemic regions

Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral malaria but are left stricken with epilepsy or other neurologic disorders.

2 May 2012

It's never too late to take control of diabetes

"You could live a normal life." Those were the words that 15-year-old Steve Edelman kept hearing from the nurses when he was hospitalized following his type 1 diabetes diagnosis in 1970. He wondered why they kept repeating this to him.

2 May 2012

Online assessment tool for stroke

Nearly 800,000 Americans will suffer a stroke this year, yet most people in the U.S. cannot identify stroke warning signs or risk factors. HealthONE Stroke Care hopes to change that during May's National Stroke Awareness Month with the introduction of its new Stroke Risk Profiler, an online assessment tool for adults of all ages

2 May 2012

Nanocomposite dental cavity-filling kills harmful bacteria

Scientists using nanotechology at the University of Maryland School of Dentistry have created the first cavity-filling composite that kills harmful bacteria and regenerates tooth structure lost to bacterial decay.

2 May 2012

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.

From Novo Nordisk 2 May 2012

Genalyte to highlight Maverick Detection System at immunology conferences

Genalyte, Inc., a life sciences company developing and commercializing innovative next-generation multiplexing technology, today announced that it will launch an Early Access program for its Maverick™ Detection System and multiplexed autoimmune assays at two major immunology meetings in May.

2 May 2012

Medidata first quarter revenues increase 24% to $50.4 million

Medidata Solutions, a leading global provider of cloud-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the first quarter of 2012, and provided detailed financial guidance for the second quarter and full year 2012.

2 May 2012

Cell-based test to discover molecules for treatment of ER-positive breast cancer

Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer.

2 May 2012